HAVCR2 and glioblastoma: Morimoto and colleagues successfully knocked down TIM-3 in healthy human peripheral blood-derived NK cells and showed that these reduced TIM-3 expressing NK cells also had reduced ability to inhibit glioblastoma cell growth in vitro compared to control NK cells [106].